A vicious circle between insulin resistance and inflammation in nonalcoholic fatty liver disease
Open accessThe DOI matches its Crossref record; 91 of the 91 references it cites were found in a registry or an index.
Abstract
Nonalcoholic fatty liver disease (NAFLD) comprises a spectrum of diseases, including simple steatosis, nonalcoholic steatohepatitis (NASH), liver cirrhosis and hepatocellular carcinoma. Lipotoxicity, insulin resistance (IR) and inflammation are involved in the disease process. Lipotoxicity promotes inflammation and IR, which in turn, increase adipocyte lipolysis and exacerbates lipotoxicity. Furthermore, IR and inflammation form a vicious circle, with each condition promoting the other and accelerating the development of NAFLD in the presence of lipotoxicity. As an integrator of inflammatory pathway networks, nuclear factor-kappa B (NF-κB) regulates expression of pro-inflammatory cytokines, such as tumor necrosis factor-alpha (TNF-α), interleukin 6 (IL-6), and anti-inflammatory cytokines, such as adiponectin in NAFLD. In this review, the relationships between lipotoxicity, IR and inflammation in NAFLD are discussed, with particular emphasis on the inflammatory pathways.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
Hotamisligil, G. S., Shargill, N. S., & Spiegelman, B. M. (1993) · Science · doi:10.1126/science.7678183 · Cited by 7,518
Yamauchi, T., Kamon, J., Waki, H., Terauchi, Y., Kubota, N., Hara, K., Mori, Y., Ide, T., Murakami, K., Tsuboyama-Kasaoka, N., et al. (2001) · Nature Medicine · doi:10.1038/90984 · Cited by 4,915
Inflammation and insulin resistance
Shoelson, S. E. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29069 · Cited by 4,769
Obesity induces a phenotypic switch in adipose tissue macrophage polarization
Lumeng, C. N., Bodzin, J. L., & Saltiel, A. R. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29881 · Cited by 4,664
Donnelly, K. L., Smith, C. I., Schwarzenberg, S. J., Jessurun, J., Boldt, M. D., & Parks, E. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23621 · Cited by 3,604
Youle, R. J., & Narendra, D. P. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3028 · Cited by 3,273
Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB
Cai, D., Yuan, M., Frantz, D. F., Melendez, P. A., Hansen, L., Lee, J., & Shoelson, S. E. (2005) · Nature Medicine · doi:10.1038/nm1166 · Cited by 2,245
Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities
Sanyal, A. J., Campbell–Sargent, C., Mirshahi, F., Rizzo, W. B., Contos, M. J., Sterling, R. K., Luketic, V. A., Shiffman, M. L., & Clore, J. N. (2001) · Gastroenterology · doi:10.1053/gast.2001.23256 · Cited by 2,078
Wong, R. J., Aguilar, M., Cheung, R., Perumpail, R. B., Harrison, S. A., Younossi, Z. M., & Ahmed, A. (2015) · Gastroenterology · doi:10.1053/j.gastro.2014.11.039 · Cited by 1,819
IKK-β links inflammation to obesity-induced insulin resistance
Arkan, M. C., Hevener, A. L., Greten, F. R., Maeda, S., Li, Z.-W., Long, J. M., Wynshaw-Boris, A., Poli, G., Olefsky, J., & Karin, M. (2005) · Nature Medicine · doi:10.1038/nm1185 · Cited by 1,773
Fatty acid–induced NLRP3-ASC inflammasome activation interferes with insulin signaling
Wen, H., Gris, D., Lei, Y., Jha, S., Zhang, L., Huang, M. T.-H., Brickey, W. J., & Ting, J. P.-Y. (2011) · Nature Immunology · doi:10.1038/ni.2022 · Cited by 1,698
Regulation of hepatic fatty acid oxidation and ketone body production
McGarry, J. D., & Foster, D. W. (1980) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.49.070180.002143 · Cited by 1,460 · cited 1×
“AMPK activation increases fatty acid oxidation by promoting carnitine palmitoyltransferase I flux [86] and”
Yamauchi, T., Nio, Y., Maki, T., Kobayashi, M., Takazawa, T., Iwabu, M., Okada-Iwabu, M., Kawamoto, S., Kubota, N., Kubota, T., et al. (2007) · Nature Medicine · doi:10.1038/nm1557 · Cited by 1,396 · cited 1×
“Adiponectin receptor 2 (AdipoR2) upregulates the expression of genes associated with glucose consumption by activating PPAR-α signaling [52].”
Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease
Samuel, V. T., Liu, Z.-X., Qu, X., Elder, B. D., Bilz, S., Befroy, D., Romanelli, A. J., & Shulman, G. I. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313478200 · Cited by 1,322 · cited 1×
“Hepatic IR contributes to steatosis of NAFLD by impairing insulin receptor substrate1/2 (IRS-1/2) tyrosine phosphorylation [25].”
Obesity-associated improvements in metabolic profile through expansion of adipose tissue
Kim, J.-Y., van de Wall, E., Laplante, M., Azzara, A., Trujillo, M. E., Hofmann, S. M., Schraw, T., Durand, J. L., Li, H., Li, G., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31021 · Cited by 1,310 · cited 1×
“Chronic overexpression of adiponectin results in increased subcutaneous fat and protects against diet-induced IR [48].”
Xu, A., Wang, Y., Keshaw, H., Xu, L. Y., Lam, K. S. L., & Cooper, G. J. S. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200317797 · Cited by 1,298
Xu, A., Wang, Y., Keshaw, H., Xu, L. Y., Lam, K. S. L., & Cooper, G. J. S. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17797 · Cited by 1,296
Neuschwander‐Tetri, B. A. (2010) · Hepatology · doi:10.1002/hep.23719 · Cited by 1,077 · cited 14×
“A clinical study showed that PPAR-α gene expression in human liver is negatively associated with NASH severity [72].”
InfluentialYamaguchi, K., Yang, L., McCall, S., Huang, J., Yu, X. X., Pandey, S. K., Bhanot, S., Monia, B. P., Li, Y.-X., & Diehl, A. M. (2007) · Hepatology · doi:10.1002/hep.21655 · Cited by 1,015
Tilg, H., Moschen, A. R., & Roden, M. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.147 · Cited by 1,002
Endogenous glucose production is inhibited by the adipose-derived protein Acrp30
Combs, T. P., Berg, A. H., Obici, S., Scherer, P. E., & Rossetti, L. (2001) · Journal of Clinical Investigation · doi:10.1172/jci14120 · Cited by 935
Gaggini, M., Morelli, M., Buzzigoli, E., DeFronzo, R., Bugianesi, E., & Gastaldelli, A. (2013) · Nutrients · doi:10.3390/nu5051544 · Cited by 822
PPARs in Obesity-Induced T2DM, Dyslipidaemia and NAFLD
Gross, B., Pawlak, M., Lefebvre, P., & Staels, B. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.135 · Cited by 778
Bugianesi, E., Gastaldelli, A., Vanni, E., Gambino, R., Cassader, M., Baldi, S., Ponti, V., Pagano, G., Ferrannini, E., & Rizzetto, M. (2005) · Diabetologia · doi:10.1007/s00125-005-1682-x · Cited by 770
Perry, R. J., Camporez, J.-P. G., Kursawe, R., Titchenell, P. M., Zhang, D., Perry, C. J., Jurczak, M. J., Abudukadier, A., Han, M. S., Zhang, X.-M., et al. (2015) · Cell · doi:10.1016/j.cell.2015.01.012 · Cited by 719 · cited 1×
“Compared to lean individuals, obese adolescents with IR have higher adipose tissue IL-6 concentrations than lean individuals [41].”
Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies
(2010) · The Lancet · doi:10.1016/s0140-6736(10)60545-4 · Cited by 716 · cited 1×
“pathways have negative influences on disease [17], recent evidence indicates that trigylcerides have protective activity.”
Nonalcoholic fatty liver disease: A precursor of the metabolic syndrome
Lonardo, A., Ballestri, S., Marchesini, G., Angulo, P., & Loria, P. (2015) · Digestive and Liver Disease · doi:10.1016/j.dld.2014.09.020 · Cited by 685
What if Minkowski Had Been Ageusic? An Alternative Angle on Diabetes
McGarry, J. D. (1992) · Science · doi:10.1126/science.1439783 · Cited by 657 · cited 11×
“AMPK activation exacerbates NAFLD by suppressing DNL and increasing fatty acid oxidation in liver, and promoting mitochondrial function in adipose tissue.”
InfluentialRole of leptin and adiponectin in insulin resistance
Yadav, A., Kataria, M. A., Saini, V., & Yadav, A. (2013) · Clinica Chimica Acta · doi:10.1016/j.cca.2012.12.007 · Cited by 637
JNK Expression by Macrophages Promotes Obesity-Induced Insulin Resistance and Inflammation
Han, M. S., Jung, D. Y., Morel, C., Lakhani, S. A., Kim, J. K., Flavell, R. A., & Davis, R. J. (2013) · Science · doi:10.1126/science.1227568 · Cited by 636
Fabbrini, E., Mohammed, B. S., Magkos, F., Korenblat, K. M., Patterson, B. W., & Klein, S. (2008) · Gastroenterology · doi:10.1053/j.gastro.2007.11.038 · Cited by 631
Gastaldelli, A., Cusi, K., Pettiti, M., Hardies, J., Miyazaki, Y., Berria, R., Buzzigoli, E., Sironi, A. M., Cersosimo, E., Ferrannini, E., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.04.068 · Cited by 629
AMPK as a Therapeutic Target for Treating Metabolic Diseases
Day, E. A., Ford, R. J., & Steinberg, G. R. (2017) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2017.05.004 · Cited by 619
Combs, T. P., Pajvani, U. B., Berg, A. H., Lin, Y., Jelicks, L. A., Laplante, M., Nawrocki, A. R., Rajala, M. W., Parlow, A. F., Cheeseboro, L., et al. (2004) · Endocrinology · doi:10.1210/en.2003-1068 · Cited by 545
The Subtle Balance between Lipolysis and Lipogenesis: A Critical Point in Metabolic Homeostasis
Saponaro, C., Gaggini, M., Carli, F., & Gastaldelli, A. (2015) · Nutrients · doi:10.3390/nu7115475 · Cited by 529
Treatment of nonalcoholic fatty liver disease: role of AMPK
Smith, B. K., Marcinko, K., Desjardins, E. M., Lally, J. S., Ford, R. J., & Steinberg, G. R. (2016) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00225.2016 · Cited by 500
Endoplasmic reticulum stress is reduced in tissues of obese subjects after weight loss
Gregor, M. F., Yang, L., Fabbrini, E., Mohammed, B. S., Eagon, J. C., Hotamisligil, G. S., & Klein, S. (2009) · Diabetes · doi:10.2337/db08-1220 · Cited by 488
Steinberg, G. R., Michell, B. J., van Denderen, B. J. W., Watt, M. J., Carey, A. L., Fam, B. C., Andrikopoulos, S., Proietto, J., Görgün, C. Z., Carling, D., et al. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.11.005 · Cited by 417
Modulation of NF-κB signalling by microbial pathogens
Rahman, M. M., & McFadden, G. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2539 · Cited by 400
Ip, E., Farrell, G., Hall, P., Robertson, G., & Leclercq, I. (2004) · Hepatology · doi:10.1002/hep.20170 · Cited by 383
Insulin resistance in hepatocytes and sinusoidal liver cells: Mechanisms and consequences
Leclercq, I. A., Da Silva Morais, A., Schroyen, B., Van Hul, N., & Geerts, A. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.04.002 · Cited by 359
Francque, S., Verrijken, A., Caron, S., Prawitt, J., Paumelle, R., Derudas, B., Lefebvre, P., Taskinen, M.-R., Van Hul, W., Mertens, I., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.02.019 · Cited by 357
Ye, J.-M., Doyle, P. J., Iglesias, M. A., Watson, D. G., Cooney, G. J., & Kraegen, E. W. (2001) · Diabetes · doi:10.2337/diabetes.50.2.411 · Cited by 343
Nonalcoholic Fatty Liver Disease Review: Diagnosis, Treatment, and Outcomes
Ahmed, A., Wong, R. J., & Harrison, S. A. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2015.07.029 · Cited by 327
Role of endoplasmic reticulum stress in the pathogenesis of nonalcoholic fatty liver disease
Zhang, X.-Q. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i7.1768 · Cited by 289
Roden, M., Stingl, H., Chandramouli, V, Schumann, W. C., Hofer, A., Landau, B. R., Nowotny, P., Waldhäusl, W., & Shulman, G. I. (2000) · Diabetes · doi:10.2337/diabetes.49.5.701 · Cited by 288
Inflammation in Alcoholic and Nonalcoholic Fatty Liver Disease: Friend or Foe?
Gao, B., & Tsukamoto, H. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.01.025 · Cited by 287
Harriman, G., Greenwood, J., Bhat, S., Huang, X., Wang, R., Paul, D., Tong, L., Saha, A. K., Westlin, W. F., Kapeller, R., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1520686113 · Cited by 287 · cited 1×
“phorylation on ACC activity inhibits DNL, increases fatty acid oxidation and alleviates NAFLD and IR [88].”
Controlled-release mitochondrial protonophore reverses diabetes and steatohepatitis in rats
Perry, R. J., Zhang, D., Zhang, X.-M., Boyer, J. L., & Shulman, G. I. (2015) · Science · doi:10.1126/science.aaa0672 · Cited by 283
Zelber-Sagi, S., Lotan, R., Shlomai, A., Webb, M., Harrari, G., Buch, A., Nitzan Kaluski, D., Halpern, Z., & Oren, R. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.12.011 · Cited by 277
Interleukin-6 depletion selectively improves hepatic insulin action in obesity.
Klover, P. J., Clementi, A. H., & Mooney, R. A. (2005) · Endocrinology · doi:10.1210/en.2004-1468 · Cited by 273
Moschen, A. R., Molnar, C., Geiger, S., Graziadei, I., Ebenbichler, C. F., Weiss, H., Kaser, S., Kaser, A., & Tilg, H. (2010) · Gut · doi:10.1136/gut.2010.214577 · Cited by 267
PPARα Expression Protects Male Mice from High Fat–Induced Nonalcoholic Fatty Liver1–3
Abdelmegeed, M. A., Yoo, S.-H., Henderson, L. E., Gonzalez, F. J., Woodcroft, K. J., & Song, B.-J. (2011) · The Journal of Nutrition · doi:10.3945/jn.110.135210 · Cited by 251
Circulating leptin in non-alcoholic fatty liver disease: A systematic review and meta-analysis
Polyzos, S. A., Aronis, K. N., Kountouras, J., Raptis, D. D., Vasiloglou, M. F., & Mantzoros, C. S. (2016) · Diabetologia · doi:10.1007/s00125-015-3769-3 · Cited by 248 · cited 1×
“A recent meta-analysis of 33 studies with 2612 individuals summarized the current evidence for the role of leptin in NAFLD [66].”
Discrimination Between Obesity and Insulin Resistance in the Relationship With Adiponectin
Abbasi, F., Chu, J. W., Lamendola, C., McLaughlin, T., Hayden, J., Reaven, G. M., & Reaven, P. D. (2004) · Diabetes · doi:10.2337/diabetes.53.3.585 · Cited by 245
Expression and Regulation of Adiponectin and Receptor in Human and Rat Placenta
Caminos, J. E., Nogueiras, R., Gallego, R., Bravo, S., Tovar, S., García-Caballero, T., Casanueva, F. F., & Diéguez, C. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0930 · Cited by 242
Transcription Factor Cooperativity in Early Adipogenic Hotspots and Super-Enhancers
Siersbæk, R., Rabiee, A., Nielsen, R., Sidoli, S., Traynor, S., Loft, A., Poulsen, L. L. C., Rogowska-Wrzesinska, A., Jensen, O. N., & Mandrup, S. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.04.042 · Cited by 234 · cited 1×
“In addition to its function in the regulation of metabolism, PPAR-α exerts antiinflammatory effects by regulating NF-κB [71].”
Koliwad, S. K., Streeper, R. S., Monetti, M., Cornelissen, I., Chan, L., Terayama, K., Naylor, S., Rao, M., Hubbard, B., & Farese, R. V. (2010) · Journal of Clinical Investigation · doi:10.1172/jci36066 · Cited by 233
Xu, X. J., Gauthier, M.-S., Hess, D. T., Apovian, C. M., Cacicedo, J. M., Gokce, N., Farb, M., Valentine, R. J., & Ruderman, N. B. (2012) · Journal of Lipid Research · doi:10.1194/jlr.p022905 · Cited by 229
The Role of Cytokines in Non-Alcoholic Fatty Liver Disease
Tilg, H. (2010) · Digestive Diseases · doi:10.1159/000282083 · Cited by 227
MOORE, F., WEEKES, J., & HARDIE, D. G. (1991) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1991.tb16172.x · Cited by 223
Irisin in patients with nonalcoholic fatty liver disease
Polyzos, S. A., Kountouras, J., Anastasilakis, A. D., Geladari, E. V., & Mantzoros, C. S. (2014) · Metabolism · doi:10.1016/j.metabol.2013.09.013 · Cited by 215
Phosphorylation by Akt within the ST loop of AMPK-α1 down-regulates its activation in tumour cells
Hawley, S. A., Ross, F. A., Gowans, G. J., Tibarewal, P., Leslie, N. R., & Hardie, D. G. (2014) · Biochemical Journal · doi:10.1042/bj20131344 · Cited by 215
Frühbeck, G., Catalán, V., Rodríguez, A., Ramírez, B., Becerril, S., Salvador, J., Portincasa, P., Colina, I., & Gómez-Ambrosi, J. (2017) · Scientific Reports · doi:10.1038/s41598-017-06997-0 · Cited by 211
Catecholamine-induced lipolysis in adipose tissue and skeletal muscle in obesity
Jocken, J. W. E., & Blaak, E. E. (2008) · Physiology & Behavior · doi:10.1016/j.physbeh.2008.01.002 · Cited by 209
Holden, P., & Tugwood, J. (1999) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0220001 · Cited by 201
Jiao, P., Ma, J., Feng, B., Zhang, H., Alan‐Diehl, J., Eugene‐Chin, Y., Yan, W., & Xu, H. (2011) · Obesity · doi:10.1038/oby.2010.200 · Cited by 198
Pathophysiology of Non Alcoholic Fatty Liver Disease
Petta, S., Gastaldelli, A., Rebelos, E., Bugianesi, E., Messa, P., Miele, L., Svegliati-Baroni, G., Valenti, L., & Bonino, F. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17122082 · Cited by 170
Terkeltaub, R., Yang, B., Lotz, M., & Liu-Bryan, R. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30333 · Cited by 167
Effects of weight loss induced by bariatric surgery on hepatic adipocytokine expression
Moschen, A. R., Molnar, C., Wolf, A. M., Weiss, H. G., Graziadei, I. W., Kaser, S., Ebenbichler, C. F., Stadlmann, S., Moser, P. L., & Tilg, H. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.06.016 · Cited by 150
Lê, K.-A., Mahurkar, S., Alderete, T. L., Hasson, R. E., Adam, T. C., Kim, J. S., Beale, E., Xie, C., Greenberg, A. S., Allayee, H., et al. (2011) · Diabetes · doi:10.2337/db10-1263 · Cited by 150
Organization of the gene for gelatin-binding protein (GBP28)
Saito, K., Tobe, T., Minoshima, S., Asakawa, S., Sumiya, J.-I., Yoda, M., Nakano, Y., Shimizu, N., & Tomita, M. (1999) · Gene · doi:10.1016/s0378-1119(99)00041-4 · Cited by 126
Metabolic nuclear receptor signaling and the inflammatory acute phase response
Venteclef, N., Jakobsson, T., Steffensen, K. R., & Treuter, E. (2011) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2011.04.004 · Cited by 99
Fuchs, M., & Sanyal, A. J. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.05.019 · Cited by 97 · cited 14×
“A clinical study showed that PPAR-α gene expression in human liver is negatively associated with NASH severity [72].”
InfluentialGoto, H., Hozumi, A., Osaki, M., Fukushima, T., Sakamoto, K., Yonekura, A., Tomita, M., Furukawa, K., Shindo, H., & Baba, H. (2011) · Cytokine · doi:10.1016/j.cyto.2011.09.005 · Cited by 88
Molecular mechanism for the regulation of human ACC2 through phosphorylation by AMPK
Cho, Y. S., Lee, J. I., Shin, D., Kim, H. T., Jung, H. Y., Lee, T. G., Kang, L., Ahn, Y., Cho, H., & Heo, Y.-S. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.11.029 · Cited by 87
Wu, X., Mi, Y.-Y., Yang, H., Hu, A., Zhang, Q., & Shang, C. (2013) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-013-1680-0 · Cited by 84
Liu, W., Struik, D., Nies, V. J. M., Jurdzinski, A., Harkema, L., de Bruin, A., Verkade, H. J., Downes, M., Evans, R. M., van Zutphen, T., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1525093113 · Cited by 84
Fernández-Veledo, S., Vila-Bedmar, R., Nieto-Vazquez, I., & Lorenzo, M. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0558 · Cited by 80
Ballestri, S., Nascimbeni, F., Romagnoli, D., Baldelli, E., & Lonardo, A. (2016) · Advances in Therapy · doi:10.1007/s12325-016-0306-9 · Cited by 80
Kim, Y. D., Kim, Y. H., Cho, Y. M., Kim, D. K., Ahn, S.-W., Lee, J., Chanda, D., Shong, M., Lee, C., & Choi, H.-S. (2012) · Diabetologia · doi:10.1007/s00125-012-2494-4 · Cited by 75
Masdeu, J. L., Arévalo, M. I., Vila, C., Barberà, A., Gomis, R., & Caelles, C. (2013) · Diabetes · doi:10.2337/db12-1097 · Cited by 74
Ramezani–Moghadam, M., Wang, J., Ho, V., Iseli, T. J., Alzahrani, B., Xu, A., van der Poorten, D., Qiao, L., George, J., & Hebbard, L. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.598011 · Cited by 68
Leptin: The Prototypic Adipocytokine and its Role in NAFLD
Procaccini, C., Galgani, M., Rosa, V. D., Carbone, F., Rocca, C. L., Ranucci, G., Iorio, R. F., & Matarese, G. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210791208884 · Cited by 67
Metformin increases hepatic leptin receptor and decreases steatosis in mice
Tang, X., Li, J., Xiang, W., Cui, Y., Xie, B., Wang, X., Xu, Z., & Gan, L. (2016) · Journal of Endocrinology · doi:10.1530/joe-16-0142 · Cited by 58
Zhou, X., & You, S. (2014) · Pancreas · doi:10.1097/mpa.0000000000000173 · Cited by 30
Regulation of Insulin Sensitivity by Adiponectin and its Receptors in Response to Physical Exercise
Passos, M. A. R. F., & Gonçalves, M. (2014) · Hormone and Metabolic Research · doi:10.1055/s-0034-1377026 · Cited by 29
Bauer, S., Weigert, J., Neumeier, M., Wanninger, J., Schäffler, A., Luchner, A., Schnitzbauer, A. A., Aslanidis, C., & Buechler, C. (2010) · Archives of Medical Research · doi:10.1016/j.arcmed.2010.02.010 · Cited by 27
Hossain, I. A., Akter, S., Rahman, M. K., & Ali, L. (2015) · PLoS ONE · doi:10.1371/journal.pone.0142165 · Cited by 27
Sharma, M., Vikram, N. K., Misra, A., Bhatt, S., Tarique, M., Parray, H. A., Pandey, R. M., & Luthra, K. (2013) · Molecular Biology Reports · doi:10.1007/s11033-013-2738-5 · Cited by 22
van der Wijden, C. L., de Waal, H. A. D., van Mechelen, W., & van Poppel, M. N. M. (2014) · Clinical Endocrinology · doi:10.1111/cen.12593 · Cited by 13
Cited by
Trends in insulin resistance: insights into mechanisms and therapeutic strategy
Li, M., Chi, X., Wang, Y., Setrerrahmane, S., Xie, W., & Xu, H. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01073-0 · Cited by 939
Silymarin as Supportive Treatment in Liver Diseases: A Narrative Review
Gillessen, A., & Schmidt, H. H.-J. (2020) · Advances in Therapy · doi:10.1007/s12325-020-01251-y · Cited by 490
Muzurović, E., Mikhailidis, D. P., & Mantzoros, C. (2021) · Metabolism · doi:10.1016/j.metabol.2021.154770 · Cited by 336
Atherosclerosis and Inflammation: Insights from the Theory of General Pathological Processes
Gusev, E., & Sarapultsev, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24097910 · Cited by 312
The Role of Insulin Resistance and Diabetes in Nonalcoholic Fatty Liver Disease
Fujii, H., Kawada, N., & Japan Study Group of NAFLD (JSG-NAFLD) (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21113863 · Cited by 299
Metadata
- Authors
- Chen, Z., Yu, R., Xiong, Y., Du, F., & Zhu, S.
- Venue
- Lipids in Health and Disease
- Published
- 2017-10-16
- Volume
- 16
- Issue
- 1
- Pages
- 203-203
- ISSN
- 1476-511X (ISSN-L)
- OpenAlex
- W2767025475
- Cited by
- 316
- References
- 91
- FWCI
- 16.32
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.